MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611059981 A) filed by Noida Institute Of Engineering Technology Pharmacy Institute on May 12, 2026, for A Bioavailable Iron Supplement Pharmaceutical Formulation.
Inventors include Archna Singh; and Dr. Anjna Rani.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: A bioavailable iron supplement pharmaceutical formulation is disclosed. The formulation includes an iron source core, a solubility maintaining component, an antioxidant support component, a mucosal compatibility component, a disintegration control matrix, and a pharmaceutically acceptable carrier phase. The components are arranged to maintain iron in a soluble or complexed state, moderate mucosal exposure, and provide controlled dispersion during oral administration. The formulation may be provided as tablets, capsules, granules, or coated units for improved tolerability, dose uniformity, storage stability, and patient acceptability.
Disclaimer: Curated by HT Syndication.
